Intensity of the humoral response to cytomegalovirus is associated with the phenotypic and functional status of the immune system

Journal of Virology

Volumn 87, Issue 8, 2013, Pages 4486-4495

  Alonso Arias, R ^a   Moro Garcia M A ^a   Echeverria A ^a   Solano Jaurrieta, J J ^b   Suarez Garcia F M ^c   Lopez Larrea C ^a,d  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b HOSPITAL MONTE NARANCO   (Spain)

^c Ovida Nursing Home   (Spain)

^d Section of Nephrology   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY;

ADULT; AGED; AGING; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL FRACTIONATION; CELLULAR PARAMETERS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE STATUS; IMMUNOCOMPETENCE; IMMUNOPHENOTYPING; LYMPHOCYTE DIFFERENTIATION; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; T CELL RECEPTOR EXCISION CIRCLE; VIRUS REACTIVATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CELL DIFFERENTIATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; T-LYMPHOCYTES;

CYTOMEGALOVIRUS;

EID: 84875779164     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02425-12     Document Type: Article

References (37)

1. Kutza AS, Muhl E, Hackstein H, Kirchner H, Bein G. 1998. High incidence of active cytomegalovirus infection among septic patients. Clin. Infect. Dis. 26:1076-1082.
2. Prösch S, Wendt CE, Reinke P, Priemer C, Oppert M, Kruger DH, Volk HD, Docke WD. 2000. A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation. Virology 272:357-365.
3. Stowe RP, Kozlova EV, Yetman DL, Walling DM, Goodwin JS, Glaser R. 2007. Chronic herpesvirus reactivation occurs in aging. Exp. Gerontol. 42:563-570.
4. Aiello AE, Haan M, Blythe L, Moore K, Gonzalez JM, Jagust W. 2006. The influence of latent viral infection on rate of cognitive decline over 4 years. J. Am. Geriatr. Soc. 54:1046-1054.
5. Harkins L, Volk AL, Samanta M, Mikolaenko I, Britt WJ, Bland KI, Cobbs CS. 2002. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 360:1557-1563.
6. Moro-Garcia MA, Alonso-Arias R, Lopez-Vazquez A, Suarez-Garcia FM, Solano-Jaurrieta JJ, Baltar J, Lopez-Larrea C. 2012. Relationship between functional ability in older people, immune system status, and intensity of response to CMV. Age (Dordr.) 34:479-495.
7. Simanek AM, Dowd JB, Aiello AE. 2009. Persistent pathogens linking socioeconomic position and cardiovascular disease in the US. Int. J. Epidemiol. 38:775-787.
8. Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, Aiello AE. 2011. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One 6:e16103. doi:10.1371/journal.pone.0016103.
9. Olsson J, Wikby A, Johansson B, Lofgren S, Nilsson BO, Ferguson FG. 2000. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech. Ageing Dev. 121:187-201.
10. Goronzy JJ, Lee WW, Weyand CM. 2007. Aging and T-cell diversity. Exp. Gerontol. 42:400-406.
11. Nikolich-Zugich J. 2008. Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat. Rev. Immunol. 8:512-522.
12. Blackburn SD, Shin H, Haining WN, Zou T, Workman CJ, Polley A, Betts MR, Freeman GJ, Vignali DA, Wherry EJ. 2009. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10:29-37.
13. Giunta S. 2008. Exploring the complex relations between inflammation and aging (inflamm-aging): anti-inflamm-aging remodelling of inflammaging, from robustness to frailty. Inflamm. Res. 57:558-563.
14. Alonso-Arias R, Moro-Garcia MA, Lopez-Vazquez A, Rodrigo L, Baltar J, Garcia FM, Jaurrieta JJ, Lopez-Larrea C. 2011. NKG2D expression in CD4+ T lymphocytes as a marker of senescence in the aged immune system. Age (Dordr.) 33:591-605.
15. Kang I, Hong MS, Nolasco H, Park SH, Dan JM, Choi JY, Craft J. 2004. Age-associated change in the frequency of memory CD4+T cells impairs long term CD4+ T cell responses to influenza vaccine. J. Immunol. 173: 673-681.
16. Hazenberg MD, Verschuren MC, Hamann D, Miedema F, van Dongen JJ. 2001. T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J. Mol. Med. (Berl.) 79:631-640.
17. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708-712.
18. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF, Polis MA, Haase AT, Feinberg MB, Sullivan JL, Jamieson BD, Zack JA, Picker LJ, Koup RA. 1998. Changes in thymic function with age and during the treatment of HIV infection. Nature 396:690-695.
19. Hadrup SR, Strindhall J, Kollgaard T, Seremet T, Johansson B, Pawelec G, thor Straten P, Wikby A. 2006. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J. Immunol. 176:2645-2653.
20. Chiu WK, Fann M, Weng NP. 2006. Generation and growth of CD28nullCD8+ memory T cells mediated by IL-15 and its induced cytokines. J. Immunol. 177:7802-7810.
21. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. 1997. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. U. S. A. 94: 3195-3199.
22. Saurwein-Teissl M, Lung TL, Marx F, Gschosser C, Asch E, Blasko I, Parson W, Bock G, Schonitzer D, Trannoy E, Grubeck-Loebenstein B. 2002. Lack of antibody production following immunization in old age: association with CD8(+)CD28(+) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J. Immunol. 168:5893-5899.
23. Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. 2006. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin. Infect. Dis. 43:1143-1151.
24. Reeves M, Sinclair J. 2008. Aspects of human cytomegalovirus latency and reactivation. Curr. Top. Microbiol. Immunol. 325:297-313.
25. Leng SX, Qu T, Semba RD, Li H, Yao X, Nilles T, Yang X, Manwani B, Walston JD, Ferrucci L, Fried LP, Margolick JB, Bream JH. 2011. Relationship between cytomegalovirus (CMV) IgG serology, detectable CMV DNA in peripheral monocytes, and CMV pp65(495-503)-specific CD8+ T cells in older adults. Age (Dordr.) 33:607-614.
26. Vescovini R, Biasini C, Telera AR, Basaglia M, Stella A, Magalini F, Bucci L, Monti D, Lazzarotto T, Dal Monte P, Pedrazzoni M, Medici MC, Chezzi C, Franceschi C, Fagnoni FF, Sansoni P. 2010. Intense antiextracellular adaptive immune response to human cytomegalovirus in very old subjects with impaired health and cognitive and functional status. J. Immunol. 184:3242-3249.
27. Czesnikiewicz-Guzik M, Lee WW, Cui D, Hiruma Y, Lamar DL, Yang ZZ, Ouslander JG, Weyand CM, Goronzy JJ. 2008. T cell subset-specific susceptibility to aging. Clin. Immunol. 127:107-118.
28. McFarland RD, Douek DC, Koup RA, Picker LJ. 2000. Identification of a human recent thymic emigrant phenotype. Proc. Natl. Acad. Sci. U. S. A. 97:4215-4220.
29. Trzonkowski P, Mysliwska J, Pawelec G, Mysliwski A. 2009. From bench to bedside and back: the SENIEUR Protocol and the efficacy of influenza vaccination in the elderly. Biogerontology 10:83-94.
30. Wikby A, Johansson B, Olsson J, Lofgren S, Nilsson BO, Ferguson F. 2002. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp. Gerontol. 37:445-453.
31. Strandberg TE, Pitkala KH, Tilvis RS. 2009. Cytomegalovirus antibody level and mortality among community-dwelling older adults with stable cardiovascular disease. JAMA 301:380-382.
32. Wang GC, Kao WH, Murakami P, Xue QL, Chiou RB, Detrick B, McDyer JF, Semba RD, Casolaro V, Walston JD, Fried LP. 2010. Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am. J. Epidemiol. 171: 1144-1152.
33. Kraat YJ, Christiaans MH, Nieman FH, van den Berg-Loonen PM, van Hooff JP, Bruggeman CA. 1993. Increased frequency of CMVinfection in HLA-DR7 matched renal allograft recipients. Lancet 341:494-495.
34. Schrier RD, Freeman WR, Wiley CA, McCutchan JA. 1995. Immune predispositions for cytomegalovirus retinitis in AIDS. The HNRC Group. J. Clin. Invest. 95:1741-1746.
35. Alonso-Arias R, Lopez-Vazquez A, Diaz-Pena R, Sampere A, Tricas L, Asensi V, Rodrigo L, Lopez-Larrea C. 2009. CD8dim and NKG2D expression defines related subsets of CD4+ T cells in HIV-infected patients with worse prognostic factors. J. Acquir. Immune Defic. Syndr. 51:390-398.
36. Bryl E, Vallejo AN, Matteson EL, Witkowski JM, Weyand CM, Goronzy JJ. 2005. Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis. Arthritis Rheum. 52:2996-3003.
37. Alonso-Arias R, Moro-Garcia MA, Vidal-Castineira JR, Solano-Jaurrieta JJ, Suarez-Garcia FM, Coto E, Lopez-Larrea C. 2011. IL-15 preferentially enhances functional properties and antigen-specific responses of CD4+CD28(null) compared to CD4+CD28+ T cells. Aging Cell 10:844-852.